Latest News

The new functionalities for the AI-enabled Breast Suite software include automated identification of breast arterial calcifications and integration of prior mammograms.

Catch up on the top AI-related news and research in radiology over the past month.

The First Read software provides preliminary drafting of radiology reports based on AI assessment of chest X-rays.

The Oncology Virtual Expert AI software reportedly provides semi-automated segmentation maps of brain tumors based on standard brain MRI scans.

In a recent interview discussing the SNMMI conference, Jeremie Calais, MD, PhD, shared his thoughts on emerging advances. a key mentor in nuclear medicine and combination therapy for prostate cancer.

The newly launched HOPPR Presto Agent reporting platform can be integrated into existing radiology systems and AI models without the need for new software.

In a recent interview, Constance Lehman, MD, PhD, discussed newly published research demonstrating the dynamic capability of AI-based risk scores, drawn from screening mammograms, to facilitate risk-adaptive screening.

In a recent episode of our “Molecular Imaging in Focus” series, Surekha Yadav, MBBS, MD, discussed research presented at the SNMMI conference that showed significant advantages of PSMA PET over conventional imaging for detection of osseous oligometastatic prostate cancer (PCa).

The VascularAssist Occlusion Triage software reportedly demonstrated over a 90 percent sensitivity for detecting peripheral artery disease (PAD) on CT in clinical performance testing.

Catch up on the top radiology content of the past week.

The use of FAPI PET/CT offered a 97 percent pooled sensitivity for detecting peritoneal metastases in a patient-based analysis in a new meta-analysis involving over 800 patients.

New research suggests that photon-counting CT may provide critical insight into a diagnostic dilemma that has challenged radiologists for decades.

For patients with advanced melanoma, the melanin-targeted PET radiotracer (¹⁸F)DMPY2 offered superior detection of metastatic foci in the brain and liver in comparison to (¹⁸F)FDG, according to preliminary comparative research presented at the recent SNMMI conference.